This is a correction to: Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, Nadi Wickramasekera, Sanjay Bansal, Rajesh Medisetty, Austin Miller, Wendy M Swetzig, Laxmi Silwal-Pandit, Anne-Lise Børresen-Dale, Chad J Creighton, Jun Hyoung Park, Santhi D Konduri, Alka Mukhopadhyay, Alexander Caradori, Angela Omilian, Wiam Bshara, Benny Abraham Kaipparettu, Gokul M Das, TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer, JNCI: Journal of the National Cancer Institute, Volume 111, Issue 11, November 2019, Pages 1202–1215, https://doi.org/10.1093/jnci/djz051
In the originally published version of this manuscript, in the flow cytometry analysis data in Figure 3 A & C, panels were interchanged and panels were misplaced in Figure 4 F. The correct figure panels are shown below.
In the protein expression sub-figure (bottom panel) section of Supplementary Figure 4C, an incorrect protein expression figure for MDA-MB-231 was shown. The panel with the correct figure is shown below.
The authors take responsibility and apologize for the inadvertent errors. The interpretation of the data in these figures and conclusion from them in the article do not change because of the correction.
In the ‘Notes’ section, affiliation for Dr. Benny Abraham Kaippparettu (BAK) who is in the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX is missing. The sentence “…; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX (JHP);” should be corrected to “…; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX (JHP, BAK);”
These details have been corrected only in this correction notice to preserve the published version of record.